25 May 2013
Keywords: bayer, faces, german, prosecutor, enquiry, following, company
Article | 05 September 2001
Following the company's recent withdrawal of its cholesterol-loweringdrug Lipobay/Baycol (cerivastatin; Marketletters passim), Bayer is now allegedly faced with an ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.